BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 10935427)

  • 1. New perspectives in the drug treatment of Kawasaki disease.
    Shingadia D; Shulman ST
    Paediatr Drugs; 1999; 1(4):291-7. PubMed ID: 10935427
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Six Kawasaki disease patients with acute coronary artery thrombosis].
    Zhou SL; Luo JP; Qi YQ; Liang YG; Wang W; Gong FQ
    Zhonghua Er Ke Za Zhi; 2013 Dec; 51(12):925-9. PubMed ID: 24495764
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Histopathologic and coronary angiographic assessment of effectiveness of aspirin or aspirin-and-gammaglobulin in Kawasaki disease.
    Haneda N; Mori C
    Acta Paediatr Jpn; 1993 Aug; 35(4):294-7. PubMed ID: 7691025
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Kawasaki disease: part II. Complications and treatment.
    Bayers S; Shulman ST; Paller AS
    J Am Acad Dermatol; 2013 Oct; 69(4):513.e1-8; quiz 521-2. PubMed ID: 24034380
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Kawasaki disease: a comprehensive review of treatment options.
    Patel RM; Shulman ST
    J Clin Pharm Ther; 2015 Dec; 40(6):620-5. PubMed ID: 26547265
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment of acute Kawasaki disease: aspirin's role in the febrile stage revisited.
    Hsieh KS; Weng KP; Lin CC; Huang TC; Lee CL; Huang SM
    Pediatrics; 2004 Dec; 114(6):e689-93. PubMed ID: 15545617
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High-dose intravenous gammaglobulin for Kawasaki disease.
    Furusho K; Kamiya T; Nakano H; Kiyosawa N; Shinomiya K; Hayashidera T; Tamura T; Hirose O; Manabe Y; Yokoyama T
    Lancet; 1984 Nov; 2(8411):1055-8. PubMed ID: 6209513
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Selective high dose gamma-globulin treatment in Kawasaki disease: assessment of clinical aspects and cost effectiveness.
    Sato N; Sugimura T; Akagi T; Yamakawa R; Hashino K; Eto G; Iemura M; Ishii M; Kato H
    Pediatr Int; 1999 Feb; 41(1):1-7. PubMed ID: 10200128
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Kawasaki disease: management guidelines.
    Nieves-Rivera F; Martin Pumarejo M; Villavicencio R
    Bol Asoc Med P R; 1988 Feb; 80(2):51-3. PubMed ID: 2450550
    [No Abstract]   [Full Text] [Related]  

  • 10. Overview of pharmacological treatment of Kawasaki disease.
    Onouchi Z; Kawasaki T
    Drugs; 1999 Nov; 58(5):813-22. PubMed ID: 10595862
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High-Dose Aspirin is Associated with Anemia and Does Not Confer Benefit to Disease Outcomes in Kawasaki Disease.
    Kuo HC; Lo MH; Hsieh KS; Guo MM; Huang YH
    PLoS One; 2015; 10(12):e0144603. PubMed ID: 26658843
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Evaluation of unresponsiveness to standard high-dose gamma globulin therapy in Kawasaki disease].
    Tavli V; Yilmazer MM; Güven B; Meşe T; Oner T; Demirpençe S
    Turk Kardiyol Dern Ars; 2010 Jan; 38(1):20-4. PubMed ID: 20215838
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Effects of three intravenous gamma globulin regimens on Kawasaki disease and relevant coronary complication rates in pediatric patients: a comparative study].
    DU ZD; Zhao D; DU JB; Lu S; Yi JM; Hou AC; Zhou ZS; Ding GF;
    Zhonghua Yi Xue Za Zhi; 2007 Nov; 87(44):3119-21. PubMed ID: 18269869
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Initial intravenous gammaglobulin treatment failure in Kawasaki disease.
    Wallace CA; French JW; Kahn SJ; Sherry DD
    Pediatrics; 2000 Jun; 105(6):E78. PubMed ID: 10835091
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term changes in coronary artery aneurysms in patients with Kawasaki disease: comparison of therapeutic regimens.
    Onouchi Z; Hamaoka K; Sakata K; Ozawa S; Shiraishi I; Itoi T; Kiyosawa N
    Circ J; 2005 Mar; 69(3):265-72. PubMed ID: 15731529
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Kawasaki syndrome.
    Rowley AH; Gonzalez-Crussi F; Shulman ST
    Adv Pediatr; 1991; 38():51-74. PubMed ID: 1718150
    [No Abstract]   [Full Text] [Related]  

  • 17. Pharmacological therapy for patients with Kawasaki disease.
    Williams RV; Minich LL; Tani LY
    Paediatr Drugs; 2001; 3(9):649-60. PubMed ID: 11688596
    [TBL] [Abstract][Full Text] [Related]  

  • 18. American Academy of Pediatrics, Committee on Infectious Diseases: Intravenous gamma-globulin use in children with Kawasaki disease.
    Pediatrics; 1988 Jul; 82(1):122. PubMed ID: 2454444
    [No Abstract]   [Full Text] [Related]  

  • 19. New hope for children with Kawasaki disease.
    Lux KM
    J Pediatr Nurs; 1991 Jun; 6(3):159-65. PubMed ID: 1710660
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Kawasaki disease and its cardiac sequelae.
    Sundel RP; Newburger JW
    Hosp Pract (Off Ed); 1993 Nov; 28(11):51-4, 57-60, 64-6. PubMed ID: 7693740
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.